Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,013.8
-0.9 (-0.03%)

 

  • STI Straits Times Index
    3,013.8
    -0.9 (-0.03%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,600.1
    18.9 (1.19%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    29,098.3
    -138.5 (-0.47%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,502.0
    -1.5 (-0.04%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,864.3
    -65.8 (-0.23%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,258.7
    -32.1 (-0.51%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,088.5M
  • Value: 1,589.7M
  • Rise: 159
  • Fall: 161
  • Unch: 454

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
FJ Benjamin0.044+0.001
Oceanus^0.043-
HGH0.012-0.002
Sembcorp Marine0.157-
CWX Global0.005+0.001
Thomson Medical0.108+0.002
Arion Ent0.017-0.005
ICP Ltd0.012+0.002
Shen Yao0.004+0.001
Jasper Inv0.005-

World Indices

World Indices
Name Last Change
Nasdaq 12,723.5 -274.3
HSI 29,098.3 -138.5
HSCEI 11,292.2 -33.4
Jakarta 6,258.7 -32.0
Nikkei 225 28,864.3 -65.8
SSE Comp 3,502.0 -1.5
Shanghai A 3,670.8 -1.6
Shanghai B 244.9 -1.1
KOSPI 3,026.3 -17.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ZAI LAB LIMITED ADS EACH REP 1 ORD SHS ZAI LAB LIMITED ADS EACH REP 1 ORD SHS
Updated on 04 Mar 2021 (End of trading day)
Last (USD): 133.070 Change: -7.600 High: 142.310 Remarks: -
Change (%): -5.40 Low: 131.630
Open 138.410 Yesterday's Close 140.67
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 655,450 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -3.06016 Trailing EPS (USD) e -3.06016 NAV (USD) b 13.2844
PE a - Trailing PE f - Price / NAV b 10.0170
Dividend (USD) d - Cash In Hand (USD) g 5.0227 Issued & Paid-up Shares c 88,024,200
Dividend Yield (%) d - Price / Cash In Hand g 26.494 Treasury Shares h -
Market Cap (M) 11,713.380 Enterprise Value (M) 10,545.185
Piotroski F Score 4 Exchange Code ZLAB Par Value ( $ ) n.a.
52 Weeks Volatility (%) 55.62 Free Float (%) 94.9
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 13 Nov 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 19 Sep 2017.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ZAI LAB LIMITED ADS EACH REP 1 ORD SHS NASDAQ 11,713.380 - - 10.0170 -
Industry Biotechnology NASDAQ 2,824.731 1438.131 - 6.7670 0.631
Local Peer AMGEN INC NASDAQ 128,167.671 17.644 17.644 13.6218 2.888
Local Peer GILEAD SCIENCES INC NASDAQ 79,454.186 645.995 645.969 4.3651 4.293
Local Peer ILLUMINA INC NASDAQ 58,303.099 88.877 88.877 12.4208 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 54,017.088 19.920 19.920 6.2183 -
Local Peer MODERNA INC NASDAQ 52,889.571 - - 20.6490 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 48,142.965 13.703 13.703 4.3666 -
Local Peer BIOGEN INC NASDAQ 40,151.200 10.036 10.036 3.7523 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 32,638.634 54.091 54.091 2.8013 -
Local Peer 10X GENOMICS INC NASDAQ 25,334.463 - - 34.2791 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 26,456.399 - - 6.8376 -
Local Peer SEAGEN INC NASDAQ 26,350.304 42.939 42.939 7.5544 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 22,662.161 - - 20.8320 -
Other Local Peers EXACT SCIENCES CORP (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), BIO-TECHNE CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), NOVAVAX INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ACCELERON PHARMA (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), EXELIXIS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), TG THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), ARVINAS INC (NASDAQ), VERACYTE INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), SEER INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ALKERMES PLC (NASDAQ), VIELA BIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), NANTKWEST INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), ALLOVIR INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), OCUGEN INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), REGENXBIO INC (NASDAQ), PRECIGEN INC (NASDAQ), BIOATLA INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), SERES THERAPEUTICS (NASDAQ), TRANSLATE BIO INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), NKARTA INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), IMMUNOVANT INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), VAXCYTE INC (NASDAQ), ALECTOR INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), OMEROS CORP (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), INHIBRX INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), CORTEXYME INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), VANDA PHARMACE INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), RADIUS HEALTH INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), CHIMERIX INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), MERUS B V (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), HUMANIGEN INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), CURIS INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), KADMON HLDGS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), VAXART INC (NASDAQ), COMPUGEN (NASDAQ), VBI VACCINES INC CDA (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), AKOUOS INC (NASDAQ), IMMATICS N V (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), ATRECA INC (NASDAQ), AFFIMED N V (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), AGENUS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), IVERIC BIO INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), ALTIMMUNE INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ADICET BIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), AVROBIO INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SESEN BIO INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), XOMA CORP (NASDAQ), VERASTEM INC (NASDAQ), ONCORUS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), IMMUNOME INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), ATHERSYS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), BIOVIE INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), NEXTCURE INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), KAMADA LTD (NASDAQ), CABALETTA BIO INC (NASDAQ), MEDICINOVA INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), INMUNE BIO INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), METACRINE INC (NASDAQ), IMV INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CHIASMA INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), EQUILLIUM INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), EVOGENE LTD (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ORGENESIS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), LONGEVERON INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), SYNLOGIC INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ARAVIVE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), OTONOMY INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), SAVARA INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), COHBAR INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ADVAXIS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), BIOCARDIA INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), SOLIGENIX INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ATYR PHARMA INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), PRECIPIO INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), HISTOGEN INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), GEOVAX LABS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENESTECH INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ)
Global Peer CSL LTD ASX 113,106.883 36.064 29.720 10.7034 1.181
Global Peer WUXI BIO HKEx 376,808.425 327.779 261.689 25.2248 -
Global Peer BEIGENE HKEx 206,102.804 - - 6.8697 -
Global Peer SINO BIOPHARM HKEx 155,778.537 50.754 60.874 4.3222 0.644
Global Peer ZAI LAB-SB HKEx 89,608.636 - - 9.8830 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 4,843.371 15.875 15.875 3.3472 -
Global Peer JOINN HKEx 35,742.934 167.813 146.464 32.3617 0.174
Global Peer Lonza SGX 5,940.891 4.560 4.560 0.5844 5.624
Global Peer GENSCRIPT BIO HKEx 26,390.789 - - 3.6095 -
Global Peer 3SBIO HKEx 19,026.128 17.232 12.671 1.6265 -
Other Global Peers ARCUS BIOSCIENCES INC (NYSE), NUVATION BIO INC (NYSE), MYOVANT SCIENCES LTD (NYSE), JACOBIO-B (HKEx), JW THERAP-B (HKEx), ALPHAMAB-B (HKEx), VIVA BIOTECH (HKEx), HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), POLYNOVO LIMITED (ASX), MESOBLAST LTD (ASX), JHBP-B (HKEx), ASCENTAGE-B (HKEx), TELIX PHARMACEUTIC (ASX), KINTOR PHARMA-B (HKEx), ACTINIUM PHARMACEUTICALS INC (NYSE American), SINOMAB BIO-B (HKEx), DPHARMA (Bursa), ESSEX BIO-TECH (HKEx), OPTHEA LIMITED (ASX), ASCLETIS-B (HKEx), LEE'S PHARM (HKEx), SQZ BIOTECHNOLOGIES CO (NYSE), IMUGENE LIMITED (ASX), NANOVIRICIDES INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), ANTEOTECH LIMITED (ASX), 22ND CENTURY GROUP INC (NYSE American), BIONOMICS LTD (ASX), NEXT SCIENCE LTD (ASX), BIOMX INC (NYSE American), IMMUTEP LTD (ASX), CEL-SCI CORP (NYSE American), IBIO INC (NYSE American), ENZO BIOCHEM INC (NYSE), KAZIA THERAPEUTICS LIMITED (ASX), NEUREN PHARMACEUTICALS LTD (ASX), PALATIN TECHNOLOGIES INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), LEAF RESOURCES LTD (ASX), GENETIC TECHNOLOGIES (ASX), UNI-BIO GROUP (HKEx), SYNTHETIC BIOLOGICS INC (NYSE American), CHIMERIC THERAPEUTICS LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), REGENT PACIFIC (HKEx), MEMPHASYS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), ORAGENICS INC (NYSE American), BIOTRON (ASX), PATRYS LIMITED (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), Suntar Eco-City (SGX), ADALTA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), REGENEUS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), RHINOMED LIMITED (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), HOLISTA COLLTECH LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), NANOLLOSE LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), CRYOSITE (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --14.450
-9.80 %
10 Days --42.290
-24.12 %
20 Days --44.450
-25.04 %
Medium Term Return 3 Months -+25.070
+23.21 %
6 Months -+55.160
+70.80 %
1 Year -+79.510
+148.45 %
Long Term Return 2 Years -+105.320
+379.53 %
3 Years -+110.970
+502.13 %
Annualised Return Annualised --
+81.93 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 43.060 - 193.540 Change From 1 Year Low +90.010 % Change From 1 Year Low (%) +209.03
Change From 1 Year High -60.470 % Change From 1 Year High (%) -31.24
2 Years Range 23.415 - 193.540 Change From 2 Years Low +109.655 % Change From 2 Years Low (%) +468.31
Change From 2 Years High -60.470 % Change From 2 Years High (%) -31.24
5 Years Range 14.290 - 193.540 Change From 5 Years Low +118.780 % Change From 5 Years Low (%) +831.21
Change From 5 Years High -60.470 % Change From 5 Years High (%) -31.24
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Zai Lab Ltd. is a biopharmaceutical company. It engages in the discovering, licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need in the fields of oncology, infectious and autoimmune diseases. The company's products include Zejula and Optune. Zai Lab was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.

Historical Price Data

Date Open High Low Close Volume VWAP
04 Mar 2021 138.410 142.310 131.630 133.070 655,450 -
03 Mar 2021 147.970 147.970 138.920 140.670 472,470 -
02 Mar 2021 157.000 161.345 145.090 148.010 433,176 -
01 Mar 2021 148.970 163.720 145.000 162.020 370,163 -
26 Feb 2021 146.690 150.880 144.100 147.520 539,393 -
25 Feb 2021 158.090 158.485 146.120 147.390 871,607 -
24 Feb 2021 160.610 161.200 155.000 156.900 369,074 -
23 Feb 2021 161.070 163.705 152.330 161.680 417,914 -
22 Feb 2021 172.650 174.100 166.380 166.790 417,015 -
19 Feb 2021 173.320 176.410 168.010 175.360 269,570 -
18 Feb 2021 172.860 174.680 168.500 171.470 275,451 -
17 Feb 2021 176.000 178.240 173.030 176.800 479,556 -
16 Feb 2021 184.420 184.500 176.160 177.700 296,097 -
12 Feb 2021 182.790 185.280 179.530 182.570 98,468 -
11 Feb 2021 180.000 183.430 178.755 182.330 241,770 -
10 Feb 2021 184.800 187.460 179.010 179.820 292,559 -
09 Feb 2021 185.000 186.680 182.010 183.830 337,129 -
08 Feb 2021 178.550 186.090 178.550 183.600 233,595 -
05 Feb 2021 178.250 180.670 176.430 177.520 186,733 -
04 Feb 2021 173.970 179.060 172.170 178.250 225,757 -
03 Feb 2021 174.910 175.240 168.000 173.350 422,771 -
02 Feb 2021 167.190 177.640 163.000 176.780 560,812 -
Summary
Current 2 Weeks
(19 Feb 2021 to 04 Mar 2021)
173.320 176.410 131.630 133.070 4,815,832 -
Previous 2 Weeks
(04 Feb 2021 to 18 Feb 2021)
173.970 179.060 131.630 171.470 2,667,115 -
4 Weeks from
(06 Jan 2021 to 03 Feb 2021)
135.930 176.410 127.090 173.350 8,912,167 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.